One-year data suggest allogeneic stem cell-derived islet-cell therapy could become a future option for those with type 1 ...

Novo Nordisk rebounds from 2024 lows as GLP-1 supply issues ease, partnerships expand, and valuation turns attractive. Find ...

Overweight patients given an experimental weight loss drug being developed by China's Sciwind Biosciences lost an average of ...

An obesity drug from China helped patients lose a lot of weight in a late-stage clinical trial, making it a prospective new ...

A new generation of weight-loss drugs has proven remarkably effective, hugely popular and massively lucrative in the last few ...

New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...

Eli Lilly & Co.’s experimental weight-loss pill helped patients shed pounds without serious side effects in a clinical trial, burnishing the drug’s blockbuster potential in the company’s competition ...

A protocol designed for primary care increased weight loss across a quarter of a million people, but only 25% of those with a ...

The first diabetes and obesity pill that is similar to Ozempic — but in tablet form — may actually outperform the popular ...

This would make amycretin a more effective than other weight loss drugs like Wegovy, where a trial found that patients lost ...

A weight loss pill might be able to replace the notorious injections as per new studies.Researchers found that amycretin, ...